Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study / Alberici, Laura; Antonacci, Filippo; Arena, Alessandro; Belvedere, Angela; Bernagozzi, Fabio; Bernante, Paolo; Bertoglio, Pietro; Bianchi, Lorenzo; Bisulli, Maria; Bonfanti, Barbara; Boussedra, Safia; Brandolini, Jury; Cacciapuoti, Crescenzo; Cardelli, Stefano; Casadei, Riccardo; Cescon, Matteo; Cipolli, Alessandro; Cipriani, Riccardo; Contu, Luca; Costa, Francesco; Daddi, Niccolo’; De Crescenzo, Eugenia; De Iaco, Pierandrea; De Palma, Alessandra; Del Gaudio, Massimo; Nunzia Della Gatta, Anna; Dolci, Giampiero; Dondi, Giulia; Droghetti, Matteo; Nicola Forti Parri, Sergio; Garelli, Elena; Gelati, Chiara; Germinario, Giuliana; Giorgini, Federico A.; Ingaldi, Carlo; Jovine, Elio; Kawamukai, Kenji; Lanci Lanci, Antonio; Lombardi, Raffaele; Lozano Miralles, Maria Elisa; Marchetti, Claudio; Masetti, Michele; Minni, Francesco; Morezzi, Daniele; Parlanti, Daniele; Pellegrini, Alice; Myriam Perrone, Anna; paola Pezzuto, Anna; Pignatti, Marco; Pilu, Gianluigi; Pinto, Valentina; Poggioli, Gilberto; Bernadetta Puglisi, Silvana; Raimondo, Diego; Ravaioli, Matteo; Ricci, Claudio; Ricciardi, Sara; Ricotta, Francesco; Rizzo, Roberta; Romano, Angela; Rottoli, Matteo; Schiavina, Riccardo; Seracchioli, Renato; Serenari, Matteo; Serra, Margherita; Solaini, Leonardo; Solli, Piergiorgio; Sorbi, Gioia; Taffurelli, Mario; Tanzanu, Marta; Tarsitano, Achille; Tesei, Marco; Vago, Gabriele; Violante, Tommaso; Zanotti, Simone; Frisoni, Tommaso. - In: BRITISH JOURNAL OF SURGERY. - ISSN 0007-1323. - 108:9(2021), pp. 1056-1063. [10.1093/bjs/znab101]
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
Safia Boussedra;Luca Contu;Elio Jovine;Maria Elisa Lozano Miralles;Claudio Marchetti;Francesco Minni;Marco Pignatti;
2021
Abstract
Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2021 - BJS - SARS-CoV-2 Vaccination modelling for safe surgery - COVIDSurg Week.pdf
Open access
Tipologia:
Versione pubblicata dall'editore
Dimensione
248 kB
Formato
Adobe PDF
|
248 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
